---
figid: PMC7815887__thoraxjnl-2020-215167f02
figtitle: T2 inflammatory pathway (eosinophilic COPD and asthma) and the target sites
  for anti-IL-5 agents
organisms:
- NA
pmcid: PMC7815887
filename: thoraxjnl-2020-215167f02.jpg
figlink: pmc/articles/PMC7815887/figure/F2/
number: F2
caption: The T2 inflammatory pathway (eosinophilic COPD and asthma) and the target
  sites for anti-IL-5 agents. Adapted with permission of 2019 Dove Medical Press Limited,
  from ‘Targeting IL-5 in COPD,’ by Narendra DK and Hanania Na, Int J COPD 2019;14:1045–51.
  COPD, chronic obstructive pulmonary disease; IL, interleukin.
papertitle: 'Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable
  trait.'
reftext: Benjamin David, et al. Thorax. 2021 Feb;76(2):188-195.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9541569
figid_alias: PMC7815887__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7815887__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7815887__thoraxjnl-2020-215167f02.html
  '@type': Dataset
  description: The T2 inflammatory pathway (eosinophilic COPD and asthma) and the
    target sites for anti-IL-5 agents. Adapted with permission of 2019 Dove Medical
    Press Limited, from ‘Targeting IL-5 in COPD,’ by Narendra DK and Hanania Na, Int
    J COPD 2019;14:1045–51. COPD, chronic obstructive pulmonary disease; IL, interleukin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL25
  - MYDGF
  - TSLP
  - IL33
  - PTGDR2
  - IL13
  - IL4
  - IL5
  - GATA3
  - IGHE
  - SPACA9
  - SPG21
  - IL5RA
---
